Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where F. Hinnen is active.

Publication


Featured researches published by F. Hinnen.


Applied Radiation and Isotopes | 2012

[18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18 kDa with PET: automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls.

Bertrand Kuhnast; Annelaure Damont; F. Hinnen; Tony Catarina; Stéphane Demphel; Stéphane Le Helleix; Christine Coulon; Sébastien Goutal; Philippe Gervais; Frédéric Dollé

Imaging of TSPO 18 kDa with PET is more and more considered as a relevant biomarker of inflammation in numerous diseases. Development of new radiotracers for TSPO 18 kDa has seen acceleration in the last years and the challenge today is to make available large amounts of such a radiotracer in compliance with GMP standards for application in humans. We present in this technical note automated productions of [(18)F]DPA-714, [(18)F]PBR111 and [(18)F]FEDAA1106, three promising radiotracers for TSPO 18 kDa imaging, using a TRACERlab FX-FN synthesizer. This note also includes the quality control data of the validation batches for the manufacturing qualification of clinical production of [(18)F]DPA-714.


Journal of Cerebral Blood Flow and Metabolism | 2008

Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach.

Jean-Dominique Gallezot; Michel Bottlaender; Jacques Delforge; Héric Valette; Wadad Saba; Frédéric Dollé; Christine Coulon; Michèle P Ottaviani; F. Hinnen; André Syrota; Marie-Claude Grégoire

The multiinjection approach was used to study in vivo interactions between α4β2* nicotinic acetylcholine receptors and 2-[18F]fluoro-A-85380 in baboons. The ligand kinetics was modeled by the usual nonlinear compartment model composed of three compartments (arterial plasma, free and specifically bound ligand in tissue). Arterial blood samples were collected to generate a metabolite-corrected plasma input function. The experimental protocol, which consisted of three injections of labeled or unlabeled ligand, was aiming at identifying all parameters in one experiment. Various parameters, including Bmax (the binding sites density) and KdVR (the apparent in vivo affinity of 2-[18F]fluoro-A-85380) could then be estimated in thalamus and in several receptor-poor regions. Bmax estimate was 3.0±0.3 pmol/mL in thalamus, and ranged from 0.25 to 1.58 pmol/ml_ in extrathalamic regions. Although KdVR could be precisely estimated, the association and dissociation rate constants kon/VR and koff could not be identified separately. A second protocol was then used to estimate koff more precisely in the thalamus. Having estimated all model parameters, we performed simulations of 2-[18F]fluoro-A-85380 kinetics to test equilibrium hypotheses underlying simplified approaches. These showed that a pseudo-equilibrium is quickly reached between the free and bound compartments, a favorable situation to apply Logan graphical analysis. In contrast, the pseudo-equilibrium between the plasma and free compartments is only reached after several hours. The ratio of radioligand concentration in these two compartments then overestimates the true equilibrium value, an unfavorable situation to estimate distribution volumes from late images after a bolus injection.


Journal of Labelled Compounds and Radiopharmaceuticals | 2003

2-, 3- and 4-[18F]Fluoropyridine by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222- a comparative study: 2-, 3- and 4-[18F] FLUOROPYRIDINE

M. Karramkam; F. Hinnen; Françoise Vaufrey; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2003

Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the N‐(4‐[18F]fluorobenzyl)‐2‐bromoacetamide reagent

Bertrand Kuhnast; F. Hinnen; Raphaël Boisgard; Bertrand Tavitian; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2007

Fluorine-18 labelling of small interfering RNAs (siRNAs) for PET imaging†

Thomas Viel; Bertrand Kuhnast; F. Hinnen; Raphaël Boisgard; Bertrand Tavitian; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2008

[18F]FPyKYNE, a fluoropyridine-based alkyne reagent designed for the fluorine-18 labelling of macromolecules using click chemistry

Bertrand Kuhnast; F. Hinnen; Bertrand Tavitian; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2003

Fluorine-18- and iodine-125-labelling of spiegelmers

Bertrand Kuhnast; Sven Klussmann; F. Hinnen; Raphaël Boisgard; Bernard Rousseau; Jens Peter Fürste; Bertrand Tavitian; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2003

Efficient synthesis of [11C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET

Frédéric Dollé; Yann Bramoulle; F. Hinnen; Stéphane Demphel; Pascal George; Michel Bottlaender


Journal of Labelled Compounds and Radiopharmaceuticals | 2005

Fluorine-18 labelling of PNAs functionalized at their pseudo-peptidic backbone for imaging studies with PET

Bertrand Kuhnast; F. Hinnen; Ramin Hamzavi; Raphaël Boisgard; Bertrand Tavitian; Peter E. Nielsen; Frédéric Dollé


Journal of Labelled Compounds and Radiopharmaceuticals | 2002

Ortho-[18F]Fluoronitrobenzenes by no-carrier-added nucleophilic aromatic substitution with K[18F]F–K222—A comparative study

M. Karramkam; F. Hinnen; Yann Bramoulle; S. Jubeau; Frédéric Dollé

Collaboration


Dive into the F. Hinnen's collaboration.

Researchain Logo
Decentralizing Knowledge